Trial Profile
A randomised, crossover study of study drug 038 and controlled-release oxycodone HCl tablets in patients with chronic non-cancer pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2012
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary) ; Opioid analgesics
- Indications Pain
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Purdue Pharma
- 01 Apr 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 17 Jan 2011 Planned End Date changed from 31 Mar 2011 to 31 Mar 2012 as reported by ISRCTN: Current Controlled Trials.
- 14 Aug 2010 Planned end date (31 Mar 2011) added as reported by ISRCTN: Current Controlled Trials.